Manufacturers Life Insurance Company, The Longboard Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 113,411 shares of LBPH stock, worth $6.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,411
Previous 117,739
3.68%
Holding current value
$6.8 Million
Previous $3.18 Million
18.76%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LBPH
# of Institutions
126Shares Held
34.9MCall Options Held
28.9KPut Options Held
13.9K-
Farallon Capital Management LLC San Francisco, CA3.15MShares$189 Million0.53% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.91MShares$174 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$167 Million6.52% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$122 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $815M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...